Are acting and omitting morally equivalent? A reappraisal.

Are acting and omitting morally equivalent? A reappraisal. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Are acting and omitting morally equivalent? A reappraisal. Abstract Text:

Are acting and omitting morally equivalent? A reappraisal. Publishing Authors By Initials

For similar therapeutics: patient care: withholding treatment research abstracts see: therapeutics: patient care: withholding treatment research

PUBMED ID PMID:

MEDLINE DATE:

Are acting and omitting morally equivalent? A reappraisal. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of the American Geriatrics Society

VOLUME: 43

Page Numbers: 696-701

Journal Abbreviation: J Am Geriatr Soc

ISSN: 0002-8614

DAY: 10

MONTH: Jun

YEAR: 1995

Are acting and omitting morally equivalent? A reappraisal. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7503062

Are acting and omitting morally equivalent? A reappraisal. Keywords Mesh Terms:

KEYWORDS: Withholding Treatment

MESH TERMS: legislation & jurisprudence

Chemical & Substance for Abstract: Are acting and omitting morally equivalent? A reappraisal. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Are acting and omitting morally equivalent? A reappraisal.

AFFILIATION: University of Washington School of Medicine, Department of Medical History and Ethics, Seattle, USA.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Am Geriatr Soc

REFSOURCE: J Am Geriatr Soc. 1995 Jun;43(6):716-7

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Are acting and omitting morally equivalent? A reappraisal Related Publications

• A palindrome-driven complex rearrangement of 22q11.2 and 8q24.1 elucidated using novel technologies.
• A system for interactive assessment and management in palliative care.
• Advance directives and advancing age.
• Advance directives.
• Amicrobic pyuria; a report of two cases.
• Are acting and omitting morally equivalent? A reappraisal.
• Characterization of a cryptic 3.3 Mb deletion in a patient with a "balanced t(15;22) translocation" using high density oligo array CGH and gene expression arrays.
• Clinical trial remuneration: the patients' perspective.
• Deletion 22q11.2: Report of a complex meiotic mechanism of origin.
• Detailed analysis of 22q11.2 with a high density MLPA probe set.
• Diagnostic problems. No. 3. Tuberculosis and sarcoidosis?
• Down's syndrome with G-G translocation and triple-x syndrome in the same sibship.
• Ethics. The ethics of international research with abandoned children.
• Having a difficult time leaving: experiences and attitudes of nurses with palliative sedation.
• Health-related safety: a framework to address barriers to aging in place.
• Improving access to health care: a consensus ethical framework to guide proposals for reform.
• LAPAROTOMY UNDER LOCAL ANESTHESIA AND NARCOSIS.
• Molecular cloning of a translocation breakpoint hotspot in 22q11.
• Palindrome-mediated chromosomal translocations in humans.
• Processes of adjustment to end-of-life losses: a reintegration model.
• Quality-improvement research and informed consent.
• The Cost-Coverage Trade-off: "It's Health Care Costs, Stupid".
• The axillary tail--an important caveat in prophylactic mastectomy.
• The current state of medical school education in bioethics, health law, and health economics.
• The health care directive: learning how to draft advance care documents.
• The problem with single-payer plans.
• What are bioethicists doing about health care reform?
• [Kinetics and free-radical mechanisms of tumor growth]
• [Radiosensitation of ascitic lymphosarcoma NKLy cells by chloral hydrate 4 (N,N-di(beta-oxyethyl) aminomethyl) 2,6-ditretbutylphenol]
• [The relation between radiation-protective and antineoplastic properties of inhibitors of radical processes]